CCL25
Basic information
Region (hg38): 19:8052318-8062660
Previous symbols: [ "SCYA25" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCL25 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 0 | 1 |
Variants in CCL25
This is a list of pathogenic ClinVar variants found in the CCL25 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-8053061-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
19-8053102-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
19-8056190-A-G | not specified | Uncertain significance (Apr 10, 2023) | ||
19-8056191-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
19-8056208-C-T | Benign (May 31, 2018) | |||
19-8056209-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
19-8056224-A-T | not specified | Uncertain significance (Jan 16, 2024) | ||
19-8056491-C-A | not specified | Likely benign (Apr 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCL25 | protein_coding | protein_coding | ENST00000390669 | 5 | 9884 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0152 | 0.888 | 124765 | 0 | 10 | 124775 | 0.0000401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.980 | 54 | 78.4 | 0.689 | 0.00000404 | 950 |
Missense in Polyphen | 11 | 20.654 | 0.53258 | 267 | ||
Synonymous | 0.258 | 31 | 32.9 | 0.943 | 0.00000183 | 286 |
Loss of Function | 1.39 | 4 | 8.32 | 0.481 | 4.21e-7 | 91 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000292 | 0.0000292 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000583 | 0.0000556 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000550 | 0.0000530 |
Middle Eastern | 0.0000583 | 0.0000556 |
South Asian | 0.0000816 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Potentially involved in T-cell development. Recombinant protein shows chemotactic activity on thymocytes, macrophages, THP-1 cells, and dendritics cells but is inactive on peripheral blood lymphocytes and neutrophils. Binds to CCR9. Isoform 2 is an antagonist of isoform 1. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4.;
- Pathway
- Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Intestinal immune network for IgA production - Homo sapiens (human);Chemokine signaling pathway;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- 0.428
- rvis_EVS
- 1.04
- rvis_percentile_EVS
- 91.21
Haploinsufficiency Scores
- pHI
- 0.0624
- hipred
- N
- hipred_score
- 0.203
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.154
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccl25
- Phenotype
- growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- ccl25b
- Affected structure
- caudal hematopoietic tissue
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- positive regulation of cell-matrix adhesion;monocyte chemotaxis;chemotaxis;inflammatory response;immune response;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;regulation of signaling receptor activity;neutrophil chemotaxis;positive regulation of GTPase activity;lymphocyte chemotaxis;cell chemotaxis;chemokine-mediated signaling pathway;positive regulation of ERK1 and ERK2 cascade;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor;negative regulation of leukocyte tethering or rolling
- Cellular component
- extracellular region;extracellular space
- Molecular function
- hormone activity;protein binding;chemokine activity;CCR10 chemokine receptor binding;chemokine receptor binding;CCR chemokine receptor binding